Structural evidence for a new elaborate 3D-organization of the cardiomyocyte lateral membrane in adult mammalian cardiac tissues.


Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
01 05 2019
Historique:
received: 12 02 2018
revised: 29 06 2018
accepted: 11 10 2018
pubmed: 18 10 2018
medline: 19 5 2020
entrez: 18 10 2018
Statut: ppublish

Résumé

This study explored the lateral crest structures of adult cardiomyocytes (CMs) within healthy and diseased cardiac tissue. Using high-resolution electron and atomic force microscopy, we performed an exhaustive quantitative analysis of the three-dimensional (3D) structure of the CM lateral surface in different cardiac compartments from various mammalian species (mouse, rat, cow, and human) and determined the technical pitfalls that limit its observation. Although crests were observed in nearly all CMs from all heart compartments in all species, we showed that their heights, dictated by the subsarcolemmal mitochondria number, substantially differ between compartments from one species to another and tightly correlate with the sarcomere length. Differences in crest heights also exist between species; for example, the similar cardiac compartments in cows and humans exhibit higher crests than rodents. Unexpectedly, we found that lateral surface crests establish tight junctional contacts with crests from neighbouring CMs. Consistently, super-resolution SIM or STED-based immunofluorescence imaging of the cardiac tissue revealed intermittent claudin-5-claudin-5 interactions in trans via their extracellular part and crossing the basement membrane. Finally, we found a loss of crest structures and crest-crest contacts in diseased human CMs and in an experimental mouse model of left ventricle barometric overload. Overall, these results provide the first evidence for the existence of differential CM surface crests in the cardiac tissue as well as the existence of CM-CM direct physical contacts at their lateral face through crest-crest interactions. We propose a model in which this specific 3D organization of the CM lateral membrane ensures the myofibril/myofiber alignment and the overall cardiac tissue cohesion. A potential role in the control of sarcomere relaxation and of diastolic ventricular dysfunction is also discussed. Whether the loss of CM surface crests constitutes an initial and common event leading to the CM degeneration and the setting of heart failure will need further investigation.

Identifiants

pubmed: 30329023
pii: 5133589
doi: 10.1093/cvr/cvy256
doi:

Substances chimiques

Claudin-5 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1078-1091

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Auteurs

Céline Guilbeau-Frugier (C)

Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, INSERM U1048, I2MC, 1, Avenue Jean Poulhès-BP84225, Toulouse, France.
Department of Forensic Medicine, Centre Hospitalier Universitaire de Toulouse, Université de Toulouse, Toulouse, France.
Centre de Microscopie Électronique Appliquée à la Biologie, Faculté de Médecine Rangueil, Université de Toulouse, Toulouse, France.

Marie Cauquil (M)

Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, INSERM U1048, I2MC, 1, Avenue Jean Poulhès-BP84225, Toulouse, France.

Clément Karsenty (C)

Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, INSERM U1048, I2MC, 1, Avenue Jean Poulhès-BP84225, Toulouse, France.
Department of Cardiology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
CHU Toulouse, Pediatric and Congenital Cardiology, Children's Hospital, Université de Toulouse, Toulouse, France.

Olivier Lairez (O)

Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, INSERM U1048, I2MC, 1, Avenue Jean Poulhès-BP84225, Toulouse, France.
Department of Cardiology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Camille Dambrin (C)

Department of Cardiology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Bruno Payré (B)

Centre de Microscopie Électronique Appliquée à la Biologie, Faculté de Médecine Rangueil, Université de Toulouse, Toulouse, France.

Hervé Cassard (H)

UMR IHAP, Université de Toulouse, INRA, ENVT, Toulouse, France.

Claudie Josse (C)

Centre de MicroCaractérisation Raimond Castaing, UMS 3623, Toulouse, France.

Marie-Hélène Seguelas (MH)

Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, INSERM U1048, I2MC, 1, Avenue Jean Poulhès-BP84225, Toulouse, France.

Sophie Allart (S)

Centre de Physiopathologie de Toulouse-Purpan, Université de Toulouse, INSERM, CNRS, Toulouse, France.

Maxime Branchereau (M)

Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, INSERM U1048, I2MC, 1, Avenue Jean Poulhès-BP84225, Toulouse, France.

Christophe Heymes (C)

Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, INSERM U1048, I2MC, 1, Avenue Jean Poulhès-BP84225, Toulouse, France.

Franck Mandel (F)

Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, INSERM U1048, I2MC, 1, Avenue Jean Poulhès-BP84225, Toulouse, France.

Marie-Bernadette Delisle (MB)

Centre de Microscopie Électronique Appliquée à la Biologie, Faculté de Médecine Rangueil, Université de Toulouse, Toulouse, France.
Department of Histopathology, Centre Hospitalier Universitaire de Toulouse, Université de Toulouse, Toulouse, France.

Atul Pathak (A)

Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, INSERM U1048, I2MC, 1, Avenue Jean Poulhès-BP84225, Toulouse, France.
Department of Cardiovascular Medicine, Hypertension, Risk Factors and Heart Failure Unit, Clinique Pasteur, Toulouse, France.

Etienne Dague (E)

LAAS-CNRS, Université de Toulouse, CNRS, Toulouse, France.

Jean-Michel Sénard (JM)

Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, INSERM U1048, I2MC, 1, Avenue Jean Poulhès-BP84225, Toulouse, France.
Department of Clinical Pharmacology, Centre Hospitalier Universitaire de Toulouse, Université de Toulouse, Toulouse, France.

Céline Galés (C)

Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, INSERM U1048, I2MC, 1, Avenue Jean Poulhès-BP84225, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH